X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.980
+0.180 (4.74%)
At close: Dec 5, 2025, 4:00 PM EST
3.970
-0.010 (-0.25%)
After-hours: Dec 5, 2025, 6:37 PM EST
X4 Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Net Income | -95.1 | -37.45 | -101.17 | -93.87 | -88.7 | -62.13 | Upgrade
|
| Depreciation & Amortization | 1.33 | 0.8 | 0.42 | 0.51 | 0.5 | 0.35 | Upgrade
|
| Other Amortization | 0.86 | 0.86 | 0.93 | 0.92 | 0.76 | 0.53 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -105 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 9.76 | - | Upgrade
|
| Stock-Based Compensation | 4.24 | 8.2 | 8.69 | 5.2 | 6.18 | 5.43 | Upgrade
|
| Other Operating Activities | -7.52 | -0.98 | -5.72 | 4.4 | 2.1 | 1.07 | Upgrade
|
| Change in Accounts Receivable | -0.89 | -1.07 | - | - | - | - | Upgrade
|
| Change in Inventory | -1.64 | -2.82 | - | - | - | - | Upgrade
|
| Change in Accounts Payable | -3.54 | -0.29 | 1.23 | 3.43 | 1.17 | 1.03 | Upgrade
|
| Change in Other Net Operating Assets | -2.21 | 6.85 | -0.89 | 2.31 | -2.66 | -5.09 | Upgrade
|
| Operating Cash Flow | -103.09 | -130.9 | -96.51 | -77.1 | -70.91 | -58.82 | Upgrade
|
| Capital Expenditures | -0.04 | -0.33 | -0.06 | -0.1 | -0.62 | -1.36 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 105 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -3 | -7 | - | - | - | - | Upgrade
|
| Investment in Securities | -14.28 | -30.68 | -14.82 | - | - | - | Upgrade
|
| Investing Cash Flow | -17.32 | 66.99 | -14.88 | -0.1 | -0.62 | -1.36 | Upgrade
|
| Long-Term Debt Issued | - | 20 | 22.5 | - | - | 12.39 | Upgrade
|
| Long-Term Debt Repaid | - | - | -2.06 | -0.8 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | 20 | 20.44 | -0.8 | - | 12.39 | Upgrade
|
| Issuance of Common Stock | 92.67 | 0.29 | 68.71 | 122.84 | 76.25 | 0.56 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -0.01 | -2 | -0.28 | Upgrade
|
| Other Financing Activities | - | - | -0.63 | -4.8 | - | -0.28 | Upgrade
|
| Financing Cash Flow | 92.67 | 20.29 | 88.52 | 117.23 | 74.25 | 12.39 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.03 | -0.16 | 0.1 | -0.11 | -0.32 | 0.4 | Upgrade
|
| Net Cash Flow | -27.77 | -43.77 | -22.78 | 39.92 | 2.41 | -47.38 | Upgrade
|
| Free Cash Flow | -103.13 | -131.23 | -96.57 | -77.21 | -71.52 | -60.18 | Upgrade
|
| Free Cash Flow Margin | -303.50% | -5132.07% | - | - | - | -2006.00% | Upgrade
|
| Free Cash Flow Per Share | -6.40 | -19.58 | -16.29 | -36.46 | -83.33 | -89.92 | Upgrade
|
| Cash Interest Paid | 7.77 | 7.77 | 4.6 | 3.01 | 2.91 | 2.1 | Upgrade
|
| Levered Free Cash Flow | -67.89 | -83.72 | -59.79 | -44.23 | -43.05 | -33.04 | Upgrade
|
| Unlevered Free Cash Flow | -63.13 | -79.09 | -57.1 | -42.65 | -41.53 | -31.9 | Upgrade
|
| Change in Working Capital | -6.9 | 2.68 | 0.34 | 5.74 | -1.5 | -4.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.